South Korea’s new listing market has offered little to investors this year. Just $1.5bn has been raised from IPOs in the country in 2016, compared to $3.56bn last year, according to Dealogic. The cancellation of a mammoth deal from Hotel Lotte has left investors with little to look forward to.
Not anymore. A trio of companies are preparing for IPOs that could in one quarter dwarf the amount raised throughout all of 2015.
Doosan Bobcat, Samsung BioLogics and Netmarble Games are planning IPOs that would add some $5 billion to Korea’s IPO supply, making it the strongest year for new listings since...
¬ Haymarket Media Limited. All rights reserved.
